| PACKAGING TYPE: | 5ml C-box |
| COMPOSITION: | Timolol Maleate 0.5% W/v & Brimonidine Tartrate 0.2%w/v Eye Drop |
| FORMULATION: | Drop |
| Description: | TIMOLIS-B Eye Drop is a combination ophthalmic solution used in the management of glaucoma and ocular hypertension. It combines Timolol, a beta-blocker, and Brimonidine, an alpha-2 adrenergic agonist, providing dual-action control of intraocular pressure. This combination is beneficial for patients who require additional pressure reduction beyond single-agent therapy, helping prevent optic nerve damage and vision loss. |
| Side Effects: | Eye redness or irritation Dry eyes Burning or stinging sensation Drowsiness or fatigue (due to Brimonidine) Rare systemic effects |
| How to Use: | Instill 1 drop in affected eye(s) Use as prescribed (usually twice daily) Avoid touching dropper tip Follow dosage schedule strictly |
| Precaution: | For ophthalmic use only Use under medical supervision Not recommended in asthma or severe cardiac conditions Avoid in infants unless prescribed Remove contact lenses before use |
| Product Benefits: | Effectively lowers intraocular pressure Dual-action mechanism for better control Helps manage glaucoma and ocular hypertension Reduces risk of optic nerve damage Suitable for combination therapy patients |
Frequently Asked Questions
TIMOLIS-B Eye Drop is used to reduce intraocular pressure in patients with glaucoma and ocular hypertension.
It contains Timolol Maleate 0.5% w/v and Brimonidine Tartrate 0.2% w/v.
Timolol reduces aqueous humor production, while Brimonidine decreases fluid production and increases its outflow, effectively lowering eye pressure.
You May Like
